326 related articles for article (PubMed ID: 7505359)
1. Selective inhibition of pressor and haemodynamic effects of NG-nitro-L-arginine by halothane.
Wang YX; Abdelrahman A; Pang CC
J Cardiovasc Pharmacol; 1993 Oct; 22(4):571-8. PubMed ID: 7505359
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
[TBL] [Abstract][Full Text] [Related]
3. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase.
Wang YX; Pang CC
J Pharmacol Exp Ther; 1993 Apr; 265(1):263-72. PubMed ID: 7682612
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the inhibitory effects of sodium nitroprusside, pinacidil and nifedipine on pressor response to NG-nitro-L-arginine.
Wang YX; Zhou T; Pang CC
Br J Pharmacol; 1993 Feb; 108(2):398-404. PubMed ID: 8448590
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat.
Hu CT; Chang KC; Wu CY; Chen HI
Br J Pharmacol; 1997 Nov; 122(6):1237-43. PubMed ID: 9401792
[TBL] [Abstract][Full Text] [Related]
8. Halothane impairs the hemodynamic influence of endothelium-derived nitric oxide.
Sigmon DH; Florentino-Pineda I; Van Dyke RA; Beierwaltes WH
Anesthesiology; 1995 Jan; 82(1):135-43. PubMed ID: 7832295
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
Tozer GM; Prise VE; Chaplin DJ
Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates.
Weldon SM; Winquist RJ; Madwed JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):126-33. PubMed ID: 7529307
[TBL] [Abstract][Full Text] [Related]
12. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
Joly GA; Ayres M; Chelly F; Kilbourn RG
Biochem Biophys Res Commun; 1994 Feb; 199(1):147-54. PubMed ID: 7510104
[TBL] [Abstract][Full Text] [Related]
13. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
14. Vascular pharmacodynamics of NG-nitro-L-arginine methyl ester in vitro and in vivo.
Wang YX; Poon CI; Pang CC
J Pharmacol Exp Ther; 1993 Dec; 267(3):1091-9. PubMed ID: 8263770
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
16. Increase by NG-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats.
Wang YX; Lim SL; Pang CC
Br J Pharmacol; 1995 Apr; 114(7):1454-8. PubMed ID: 7541693
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of the existence of nitric oxide-independent as well as nitric oxide-dependent vasodilator mechanisms in the in situ renal circulation in near term pregnant rats.
Chu ZM; Beilin LJ
Br J Pharmacol; 1997 Sep; 122(2):307-15. PubMed ID: 9313940
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II: nitric oxide interaction and the distribution of blood flow.
Sigmon DH; Beierwaltes WH
Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267
[TBL] [Abstract][Full Text] [Related]
19. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
Pucci ML; Lin L; Nasjletti A
J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhalation and intravenous anesthetic agents on pressor response to NG-nitro-L-arginine.
Wang YX; Zhou T; Chua TC; Pang CC
Eur J Pharmacol; 1991 Jun; 198(2-3):183-8. PubMed ID: 1864305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
